Investigating the sequential patterns of methamphetamine use initiation in Iran.
Adolescent
Adult
Age of Onset
Amphetamine-Related Disorders
/ epidemiology
Central Nervous System Stimulants
/ administration & dosage
Cross-Sectional Studies
Family
Female
Humans
Interviews as Topic
Iran
/ epidemiology
Male
Methamphetamine
/ administration & dosage
Socioeconomic Factors
Substance-Related Disorders
/ epidemiology
Young Adult
Methamphetamine (MA)
Methamphetamine use initiation
Methamphetamine use patterns
Substance sequences
Journal
Substance abuse treatment, prevention, and policy
ISSN: 1747-597X
Titre abrégé: Subst Abuse Treat Prev Policy
Pays: England
ID NLM: 101258060
Informations de publication
Date de publication:
29 07 2020
29 07 2020
Historique:
received:
18
09
2019
accepted:
22
07
2020
entrez:
31
7
2020
pubmed:
31
7
2020
medline:
2
9
2021
Statut:
epublish
Résumé
Methamphetamine (MA) remains one of the most commonly used amphetamine-type stimulants, accounting for the second most widely-used substance after marijuana. Due to increased use of MA, a wide variety of research has focused on the patterns of MA use initiation among adolescents. Nevertheless, there are few data available for people who use MA. The present study set out to assess the sequential patterns of substance use initiation in patients with MA use disorders in Iran. This cross-sectional study described substance initiation patterns for 302 patients who used MA admitted to hospitals and psychiatric centers of Shiraz University of Medical Sciences. The study was conducted between April 2015 and June 2016. After obtaining informed consents, participants were interviewed by trained interviewers using face-to-face, semi-structured interviews. The collecting data were analyzed using the chi square tests and one-way analysis of variance (ANOVA) tests to compare the relationship between qualitative and quantitative variables, respectively. Out of 302 participants enrolled in the study, 16 (5.3%) and 286 (94.7%) were female and male, respectively. The mean age of participants in the study was 37.29 years. The mean age of onset of MA use was found to be 15.9 years. 46.1% of the patients started MA use before 15 years. 77.2% of the patients who used MA had family members with a history of substance use. 93.71% of the patients who used MA started substance use with tobacco, alcohol, or opium, as the most frequent substances. Tobacco, as the first substance or starting substance, exhibited the most widely-used substance (69.53% of the cases). Tobacco-alcohol-cannabis-opium-heroin-MA sequencing was significantly related to the early onset of the substance use. Early-onset substance use was significantly higher in those with lower income, primary education, and family history of substance use. No significant relationship was found between employment status with the age of onset of substance use, and different substance use with marital status. Tobacco, alcohol and opium can be considered as the main sequencing substances for initiation to MA use. Standardized measures to decrease and control access to main starting and sequencing substances, including tobacco, alcohol, and opium, can greatly help decrease the early onset of the MA use, develop suitable prevention, and establish early intervention strategies.
Sections du résumé
BACKGROUND
Methamphetamine (MA) remains one of the most commonly used amphetamine-type stimulants, accounting for the second most widely-used substance after marijuana. Due to increased use of MA, a wide variety of research has focused on the patterns of MA use initiation among adolescents. Nevertheless, there are few data available for people who use MA. The present study set out to assess the sequential patterns of substance use initiation in patients with MA use disorders in Iran.
MATERIALS AND METHODS
This cross-sectional study described substance initiation patterns for 302 patients who used MA admitted to hospitals and psychiatric centers of Shiraz University of Medical Sciences. The study was conducted between April 2015 and June 2016. After obtaining informed consents, participants were interviewed by trained interviewers using face-to-face, semi-structured interviews. The collecting data were analyzed using the chi square tests and one-way analysis of variance (ANOVA) tests to compare the relationship between qualitative and quantitative variables, respectively.
RESULTS
Out of 302 participants enrolled in the study, 16 (5.3%) and 286 (94.7%) were female and male, respectively. The mean age of participants in the study was 37.29 years. The mean age of onset of MA use was found to be 15.9 years. 46.1% of the patients started MA use before 15 years. 77.2% of the patients who used MA had family members with a history of substance use. 93.71% of the patients who used MA started substance use with tobacco, alcohol, or opium, as the most frequent substances. Tobacco, as the first substance or starting substance, exhibited the most widely-used substance (69.53% of the cases). Tobacco-alcohol-cannabis-opium-heroin-MA sequencing was significantly related to the early onset of the substance use. Early-onset substance use was significantly higher in those with lower income, primary education, and family history of substance use. No significant relationship was found between employment status with the age of onset of substance use, and different substance use with marital status.
CONCLUSION
Tobacco, alcohol and opium can be considered as the main sequencing substances for initiation to MA use. Standardized measures to decrease and control access to main starting and sequencing substances, including tobacco, alcohol, and opium, can greatly help decrease the early onset of the MA use, develop suitable prevention, and establish early intervention strategies.
Identifiants
pubmed: 32727512
doi: 10.1186/s13011-020-00297-z
pii: 10.1186/s13011-020-00297-z
pmc: PMC7392828
doi:
Substances chimiques
Central Nervous System Stimulants
0
Methamphetamine
44RAL3456C
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
52Références
Curr Drug Res Rev. 2019;11(1):67-72
pubmed: 29749316
Ann Epidemiol. 2007 Jan;17(1):74-80
pubmed: 17140814
Traffic Inj Prev. 2009 Jun;10(3):227-30
pubmed: 19452363
Arch Pediatr Adolesc Med. 2000 Nov;154(11):1089-95
pubmed: 11074848
FP Essent. 2016 Feb;441:11-7
pubmed: 26881768
J Cosmet Dermatol. 2019 Feb;18(1):258-262
pubmed: 29781249
Addict Behav. 2007 Jan;32(1):24-38
pubmed: 16675150
J Subst Abuse Treat. 2016 Mar;62:84-8
pubmed: 26733277
J Addict Med. 2018 Mar/Apr;12(2):92-98
pubmed: 29176447
Pharmaceuticals (Basel). 2010 Jul 22;3(7):2333-2361
pubmed: 27713356
Psychopharmacology (Berl). 2017 Mar;234(5):739-747
pubmed: 28028601
J Stud Alcohol Drugs. 2014 May;75(3):423-7
pubmed: 24766754
J Clin Epidemiol. 2015 Dec;68(12):1463-71
pubmed: 26112433
Drug Alcohol Depend. 2013 May 1;129(3):167-79
pubmed: 23273775
Hum Psychopharmacol. 2019 Sep;34(5):e2710
pubmed: 31441135
Curr Opin Psychiatry. 2015 Jul;28(4):269-74
pubmed: 26001916
BMC Pediatr. 2008 Oct 28;8:48
pubmed: 18957076
Curr Med Res Opin. 1989;11(9):600-9
pubmed: 2612204
J Addict Med. 2016 Jul-Aug;10(4):269-73
pubmed: 27427901
Psychiatry Clin Neurosci. 2005 Dec;59(6):683-9
pubmed: 16401244
Drug Alcohol Rev. 2012 Sep;31(6):784-9
pubmed: 22449025
Arch Med Sci. 2012 May 9;8(2):362-7
pubmed: 22662012
Curr Opin Psychiatry. 2010 May;23(3):221-6
pubmed: 20308905
Asian J Psychiatr. 2015 Aug;16:17-25
pubmed: 26123235